Article
Therapeutic strategies for Huntington's disease
30 Jun 2020
Abstract excerpt
PURPOSE OF REVIEW: Huntington's disease is a fatal autosomal dominant neurodegenerative disorder caused by a trinucleotide expansion in the HTT gene, and current therapies focus on symptomatic treatment. This review explores therapeutic approaches that directly target the pathogenic mutation, disrupt HTT mRNA or its translation. RECENT FINDINGS: Zinc-finger transcription repressors and CRISPR-Cas9 therapies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
